BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6291761)

  • 1. Comparative studies on the quantitative analysis of experimental metastatic capacity.
    Hart IR; Talmadge JE; Fidler IJ
    Cancer Res; 1983 Jan; 43(1):400-2. PubMed ID: 6291761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
    Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA
    J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
    Talmadge JE; Fidler IJ
    J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin.
    Fidler IJ; Gruys E; Cifone MA; Barnes Z; Bucana C
    J Natl Cancer Inst; 1981 Oct; 67(4):947-56. PubMed ID: 6944560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of young nude mice for selection of subpopulations of cells with increased metastatic potential from nonsyngeneic neoplasms.
    Pollack VA; Fidler IJ
    J Natl Cancer Inst; 1982 Jul; 69(1):137-41. PubMed ID: 6954306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of organ microenvironment on pigmentation of a metastatic murine melanoma.
    Price JE; Tarin D; Fidler IJ
    Cancer Res; 1988 Apr; 48(8):2258-64. PubMed ID: 2832058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735b melanoma cells from producing metastases.
    Aukerman SL; Price JE; Fidler IJ
    J Natl Cancer Inst; 1986 Oct; 77(4):915-24. PubMed ID: 3463821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice.
    Hanna N; Fidler IJ
    Cancer Res; 1981 Feb; 41(2):438-44. PubMed ID: 7448788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse.
    Dexter DL; Lee ES; DeFusco DJ; Libbey NP; Spremulli EN; Calabresi P
    Cancer Res; 1983 Apr; 43(4):1733-40. PubMed ID: 6831418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
    Stackpole CW
    Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells.
    Hyoudou K; Nishikawa M; Umeyama Y; Kobayashi Y; Yamashita F; Hashida M
    Clin Cancer Res; 2004 Nov; 10(22):7685-91. PubMed ID: 15570002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis.
    Shi Q; Xiong Q; Wang B; Le X; Khan NA; Xie K
    Cancer Res; 2000 May; 60(10):2579-83. PubMed ID: 10825124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to intravenous tumor metastases in the athymic nude mouse: a paradoxic response.
    Richie JP; McDonald J; Gittes RF
    Surgery; 1981 Aug; 90(2):214-20. PubMed ID: 7256537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice.
    Pearlstein E; Ambrogio C; Karpatkin S
    Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active specific immunotherapy against occult brain metastasis.
    Lu W; Su J; Kim LS; Bucana CD; Donawho C; He J; Fidler IJ; Dong Z
    Cancer Res; 2003 Mar; 63(6):1345-50. PubMed ID: 12649197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor subpopulation interactions in metastasis.
    Miller FR
    Invasion Metastasis; 1983; 3(4):234-42. PubMed ID: 6677628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.